Oligio vs Thermage FLX side by side
| Topic | Oligio family | Thermage FLX |
|---|---|---|
| Manufacturer | Wontech (South Korea) | Solta Medical (USA) |
| Technology | Monopolar RF, 6.78 MHz | Monopolar RF, 6.78 MHz |
| Device design | Varies by exact model; K221989 describes a disposable tip, conductive epidermal cooling and impedance-based RF delivery | Disposable treatment tip, conductive epidermal cooling, skin-contact monitoring and RF tuning |
| US FDA record | The Oligio (trade name in 510(k) K221989); its stated US indication is electrocoagulation and soft-tissue hemostasis | Thermage FLX (510(k) K170758); its stated US indications include non-invasive treatment of wrinkles and periorbital wrinkles |
| Model caveat | K221989 describes The Oligio at a 145-W maximum; the Thai cohort reports an Oligio device at a 400-W maximum. These records should not be treated as one exact configuration | The comparison here is specifically with Thermage FLX; older Thermage generations are not automatically equivalent clinical evidence |
| Direct comparison evidence | No robust head-to-head trial establishes a universal winner | |
| Discomfort | Varies with area, settings, passes, cooling, technique and the individual; do not assume one will always hurt less | |
| How long results last | No fixed promise. Published protocols and follow-up periods differ, so a simple device-to-device duration claim is not well supported | |
| Price | Market-, area- and protocol-dependent; compare a current written quote for the exact device and treatment plan | |
| Who may be assessed | Selected people with wrinkles or mild-to-moderate laxity after an in-person medical assessment; neither replaces surgery for substantial tissue descent | |
Same broad modality — not the same device
The records discussed here describe monopolar RF at 6.78 MHz with surface cooling, but exact model identity matters. FDA K221989 is for the trade name The Oligio and lists a 145-W maximum. The Thai cohort cited below studied an Oligio device reported at a 400-W maximum. Because the names and specifications in those two primary records do not align, do not combine the clearance specifications and cohort outcomes as if they validate one exact machine; verify the model name, tip and Thai registration offered to you.
The FDA summaries also describe different output limits, monitoring features and US indications. A 510(k) finding of substantial equivalence is a regulatory route, not proof of identical cosmetic outcomes. K221989 says clinical studies were not considered necessary and none was performed for that submission, so the clearance itself is not a comparative clinical trial.
The Thai study was a prospective cohort of 30 volunteers with mild-to-moderate lower-face laxity followed for six months; 29 were women and there was no Thermage control group. Its methods list age under 45 as an eligibility criterion, while the results report ages 43–53 — an internal inconsistency that further limits generalization. The Faculty of Medicine Siriraj Hospital supported the project, Quantum Healthcare supplied the device, and Wontech funded rapid-service and open-access publication fees. The study can describe one protocol, but it cannot prove that Oligio is superior, less painful or equivalent in durability to Thermage FLX.
Pain, price and value
Sensation is not a fixed property of a brand. Energy settings, number of passes, treatment area, cooling, operator technique and individual sensitivity all matter. Published studies use different protocols, so marketing claims such as “painless” or “lasts twice as long” should not be treated as direct comparisons. Price also changes by country, clinic, area and protocol. Ask for a written quote naming the exact model, treatment area and disposable tip, then compare what is actually included.
Which should you choose? By goal
- What is the actual target: surface wrinkles, mild laxity, contour, or a problem caused mainly by volume loss?
- Is the exact model and tip registered or authorized for the proposed use in Thailand? A US FDA record does not answer that question.
- Who will assess and operate the device, and how does the plan change for your anatomy, skin thickness and medical history?
- Implanted electrical device: Thermage's official safety information says not to undergo Thermage with an implantable pacemaker, AICD/defibrillator or any other implantable electrical device. For an Oligio-family device, ask the doctor to check the exact model's instructions and Thai registration rather than assuming the rules are identical.
- If deeper jawline laxity is the concern, also compare focused ultrasound such as Ulthera; different modalities are not interchangeable.
The bottom line
Oligio and Thermage FLX share a broad RF category, but the available evidence does not justify a universal winner or fixed pain and longevity claims. A safer decision starts with the correct diagnosis, the exact registered device and tip, an experienced licensed physician, transparent pricing and realistic expectations about modest, variable change.
- US FDA 510(k) K221989 — The Oligio (regulatory record, not an endorsement or Thai authorization)
- US FDA 510(k) K170758 — Thermage FLX System
- Prospective Oligio cohort in 30 Thai volunteers — six-month follow-up, no active comparator; Siriraj supported the project, Quantum supplied the device and Wontech paid publication fees
- Thermage official safety information — contraindication for pacemakers, AICDs/defibrillators and other implantable electrical devices
- Systematic review of monopolar and bipolar RF for facial and body rejuvenation
- Thai FDA product search — verify the exact model and current registration